PhoenixBio Co (TSE:6190) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


TSE:6190 PhoenixBio Co Ltd TSE:6190
62 GF Score
Price 円324.00
GF Value 円361.16
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

PhoenixBio Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TSE:6190 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, PhoenixBio Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PhoenixBio Co Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's Margin of Safety % (DCF Earnings Based) falls into.


TSE:6190
62GF Score
PhoenixBio Co Ltd TSE:6190
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円324.00 is trading 10.3% below its estimated GF Value™ of 円361.16. GuruFocus considers PhoenixBio Co to be Modestly Undervalued.

Key valuation signals for TSE:6190:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: 円361.16 vs. price of 円324.00 (10.3% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
62GF Score

Get the complete analysis for TSE:6190

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円324.00
Price
円361.16
GF Value